Gara Jalqabaatti › Dhukkubbee Onkoloo Interstishiyali › Utah › Salt Lake City
Qorannoo klinikaalii Dhukkubbee Onkoloo Interstishiyali Salt Lake City, UT keessatti
Qorannoo 9 Dhukkubbee Onkoloo Interstishiyali f Salt Lake City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Namoota walitti qabaa jiraSadarkaa 3
- University of Utah Health Sciences Center, Salt Lake City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Namoota walitti qabaa jiraSadarkaa 3
- USA025, Salt Lake City
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, Salt Lake City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Namoota walitti qabaa jiraSadarkaa 2
- University of Utah, Salt Lake City
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Namoota walitti qabaa jira
- University of Utah, Salt Lake City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Utah Health, Salt Lake City
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Utah, Salt Lake City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Namoota walitti qabaa jiraSadarkaa 3
- University of Utah Health, Salt Lake City
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Namoota walitti qabaa jiraSadarkaa 2
- aTyr Investigative Site, Salt Lake City
Qorannoo Dhukkubbee Onkoloo Interstishiyali magaalota biroo keessatti
- New York City, NYQorannoo 18
- Philadelphia, PAQorannoo 16
- Los Angeles, CAQorannoo 14
- Charleston, SCQorannoo 13
- Kansas City, KSQorannoo 13
- Durham, NCQorannoo 13
- Chicago, ILQorannoo 12
- Houston, TXQorannoo 12
- Aurora, COQorannoo 11
- Ann Arbor, MIQorannoo 11
- Dallas, TXQorannoo 9
- Boston, MAQorannoo 9
Qorannoo biroo Salt Lake City keessatti
- Kansara Qara'a Non-Small CellQorannoo 31
- Saree (Gosoota Hunda)Qorannoo 27
- Saree OljooQorannoo 27
- Kansarii ColorectalQorannoo 22
- Dhibee QaraQorannoo 21
- MelanomaQorannoo 21
- Myeloma Baay’eeQorannoo 21
- Kansara MetastatikiiQorannoo 20
- Kansarii OvariiQorannoo 19
- ObesityQorannoo 18
- Leukemia Myeloidii HamaaQorannoo 17
- Cufama OnneeQorannoo 17
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.